1. Abstracts may only be submitted via internet. Abstracts submitted by fax or email will not be accepted.
2. All abstracts must be submitted and presented in English. Please use UK English spelling and have your abstract proofread for grammar and understanding.
3. Abstracts should contain only original material not published elsewhere prior to 9 June 2012.
4. Please structure your abstract using the following headings:
   • Objectives
   • Methods
   • Results
   • Conclusion
5. All abbreviations must be defined the first time they appear in your text. Example: Ataxia telangiectasia (AT), before being used as an abbreviation only. Do not define or use abbreviations in the title.
6. Avoid complex mathematical formulae. For the symbols = or =, type instead <= or >=. For superscript use caret (^) e.g. 10^6 instead of 106. Avoid Greek letters and symbols. Instead of “IFN-ß” use for example “IFN-beta”.
7. Tables, charts or other graphics may not be included and will be deleted by the editors.
8. Abstracts may not be longer than 2500 characters including spaces (excluding title and authors)
9. Authors should indicate their presentation preference:
   • poster presentation only
   • oral or poster presentation
   The Programme Committee reserves the right to decide on the final allocation and presentation method.
10. After having submitted your abstract, you will receive a confirmation by e-mail with your abstract reference number and personal address code and password. If you do not receive a confirmation by e-mail please contact the Abstract Hotline (check your email address!). Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal access codes.
    Corrections to abstracts can only be made up to the deadline of 03 February 2012.
11. If an abstract is accepted, one author must attend the congress and present it in person. Acceptance of the abstract implies payment of the registration fee by the presenting author.
    If a presenting author withdraws an abstract after 27 March 2012, or does not attend the session for which he or she has been scheduled, a penalty may incur prohibiting the author from presenting papers at the ENS meetings for a period of 3 years. Those subject to this penalty will be informed in writing.
12. If your research has been granted any commercial or institutional support, you will be asked to disclose this during the submission process. Please prepare a one sentence statement for this purpose.

If you have difficulties in submitting your abstracts or if you need any further information, please contact the Abstract Hotline:
Phone: +41 61 686 77 22 (Monday – Friday during CET business hours)

Authors are requested to select a topic under which they wish their abstract to be reviewed:

• Cerebrovascular disorders
• Child neurology
• Clinical neurophysiology
• Dementia/Higher function disorders
• Epilepsy
• Extrapyramidal disorders
• General neurology
• Infection
• Motor neuron disease
• Multiple sclerosis: clinical aspects
• Multiple sclerosis: pathology and pathogenesis
• Muscle disorders
• Neuro-epidemiology
• Neurogenetics
• Neuro-imaging
• Neuro-oncology
• Neuro-ophthalmology
• Neurorehabilitation
• Pain and headache
• Peripheral neuropathy
• Preclinical biology
• Sleep disorders

Authors will be notified of acceptance in March 2012 by email.

Accepted abstracts will be published in the JOURNAL OF NEUROLOGY which will be available at the meeting.

Each poster will be allocated to one of 4 poster sessions. During the 60 minute session the presence of the author will be required at the poster. Full instructions concerning the preparation and presentation will be given in the acceptance e-mail sent around the beginning of March 2012.

With their continued success last year, guided Poster-Highlight-Sessions will once again take place. Moderators will present and promote discussion of posters with the authors and interested participants

The European Neurological Society will support young scientists (born on or after 1 January 1977) who wish to attend the 22nd ENS Meeting in Prague, with a travel grant. Scientists with an excellent abstract accepted for presentation at the meeting will be considered for a travel grant. This is separate and independent of the application for the "Young Neurologists' Package".

Interested scientists should click the appropriate checkbox during the online abstract submission process. You will be required to upload a copy of your passport as proof of eligibility. Prepare this document in one of the following formats: MS Word document, gif, jpg or pdf file.
If you have difficulties uploading your passport copy, please contact the Abstract Hotline: ++41 61 686 7722

Applications without passport copy or arriving after 03 February 2012 will not be considered. Online application only.

ENS in cooperation with Faculty of 1000 (http://f1000.com) invites poster presenters at ENS 2012 to deposit his/her poster(s) following the meeting into the new open access poster repository, F1000 Posters (http://posters.f1000.com/), to enable those who could not make the meeting to see the novel work.

If you are interested in this opportunity, please tick the appropriate box when submitting your abstract online. Please note that posters not presented at the meeting or having been given a low grade during reviewing will be excluded from this offer.

F1000’s expert Faculty of ~10,000 members will then view these submissions to identify those they wish to select for inclusion in the award winning F1000 evaluation service.